论文部分内容阅读
口服溴隐亭治疗高泌乳素血症有较高的副作用发生率。作者为评价溴隐亭阴道给药法治疗高泌素血症妇女的效果,在连续非选择地对15例泌乳和高泌乳素血症妇女进行治疗。15例中10例有2～12年继发闭经史,5例月经稀发,年龄21～42岁,身高145～165cm,体重43.6～76.4kg,无服用促进泌乳素升高的药物史,甲状腺功能均正常。10例闭经者中6例对孕酮试验无反应。15例中9例CT检查证明有垂体瘤,余6例为特发性高泌乳素血症。10例(包括5例垂体瘤)曾用过口服溴隐亭2.5～20mg,停药12周后参加本研究,其停药目的只为参加此研
Oral bromocriptine treatment of hyperprolactinemia has a higher incidence of side effects. In order to assess the efficacy of bromocriptine vaginally administered to women with hyperuricemia, the authors treated 15 women with lactation and hyperprolactinemia in a continuous non-selective manner. Of the 15 patients, 10 had a secondary history of amenorrhea for 2 to 12 years, 5 had oligomenorrhea, aged 21 to 42 years old, 145 to 165 cm in height and 43.6 to 76.4 kg in body weight. There was no history of taking drugs that increased prolactin, thyroid Function is normal. Of the 10 cases of menopause, 6 showed no response to progesterone test. Nine cases of 15 cases of CT examination showed pituitary tumor, more than 6 cases of idiopathic hyperprolactinemia. 10 cases (including 5 cases of pituitary tumor) had been used oral bromocriptine 2.5 ~ 20mg, 12 weeks after withdrawal to participate in this study, the purpose of its withdrawal only to participate in this research